首页> 美国卫生研究院文献>Cell Communication and Signaling : CCS >Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine
【2h】

Csk-homologous kinase (Chk) is an efficient inhibitor of Src-family kinases but a poor catalyst of phosphorylation of their C-terminal regulatory tyrosine

机译:Csk同源激酶(Chk)是Src家族激酶的有效抑制剂但其C端调节酪氨酸磷酸化的催化剂较差

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundC-terminal Src kinase (Csk) and Csk-homologous kinase (Chk) are the major endogenous inhibitors of Src-family kinases (SFKs). They employ two mechanisms to inhibit SFKs. First, they phosphorylate the C-terminal tail tyrosine which stabilizes SFKs in a closed inactive conformation by engaging the SH2 domain in cis. Second, they employ a non-catalytic inhibitory mechanism involving direct binding of Csk and Chk to the active forms of SFKs that is independent of phosphorylation of their C-terminal tail. Csk and Chk are co-expressed in many cell types. Contributions of the two mechanisms towards the inhibitory activity of Csk and Chk are not fully clear. Furthermore, the determinants in Csk and Chk governing their inhibition of SFKs by the non-catalytic inhibitory mechanism are yet to be defined.
机译:背景C端Src激酶(Csk)和Csk同源激酶(Chk)是Src家族激酶(SFK)的主要内源性抑制剂。他们采用两种机制来抑制SFK。首先,它们使C末端的尾酪氨酸磷酸化,该酪氨酸通过将SH2结构域顺式结合而使SFKs处于封闭的非活性构象。其次,他们采用了一种非催化抑制机制,该机制涉及Csk和Chk与SFK活性形式的直接结合,而这与其C末端尾部的磷酸化无关。 Csk和Chk在许多细胞类型中共同表达。这两种机制对Csk和Chk抑制活性的贡献尚不完全清楚。此外,Csk和Chk中决定其通过非催化抑制机制抑制SFK的决定因素尚未确定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号